Video archive

An animation to accompany the study titled, "Health in times of uncertainty in the Eastern Mediterranean region, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013."

Dr. Agnes Binagwaho, a trained pediatrician and Fomer Minister of Health of Rwanda, is the second winner of the Roux Prize, a US$100,000 award for turning evidence into health impact and the largest prize of its kind. Dr. Binagwaho has used Global Burden of Disease (GBD) data and evidence from the Ministry’s own data-gathering efforts to ensure the country’s limited resources are saving the most lives and reducing suffering.

IHME Director Christopher Murray explains the amazing drop in maternal mortality since 2000 and how the Millennium Development Goals helped in The Gates Notes.

"Dr. Chris Murray and his team at the Institute for Health Metrics and Evaluation launched the Global Burden of Disease, using data from researchers around the world. The idea behind Chris's work is simple: We can't cure what we don't understand. If we know what the biggest killers are, we can make sure our efforts to save lives are aimed at the right things." - Bill Gates

IHME Director Christopher Murray presents at the 2015 EAT Food Forum on nutrition, health, and environmental sustainability.

Chief Data and Technology Officer Peter Speyer presents at Digital Health Days in Stockholm, in a session titled “How disruptive technology changes the world.” 

Despite the trillions of dollars invested into health care annually, we rarely collect systematically the end results of care – outcomes. Lacking outcome data, providers are unable to learn how good they are compared to their peers and where they can improve. This general ignorance also affects patients and payers: patients are unable to select providers who can best treat their condition, and payment is based on activity rather than results.

Overdiagnosis occurs when a tumor is detected by screening but, in the absence of screening, that tumor would never have become symptomatic within the lifetime of the patient. Thus, an overdiagnosed tumor is a true extra diagnosis due solely to the existence of the screening test. Patients who are overdiagnosed cannot, by definition, be helped by the diagnosis, but they can be harmed, particularly if they are treated.

Adolescents and young adults make up over a quarter of the global population. They can also be considered the most pervasively neglected group in global health. Yet a quiet revolution is now bringing a recognition that adolescents are central in almost every major challenge in global health. Bringing greater visibility to adolescents and their health has been an important facet of that recognition.

Professor LeVeque will introduce some of the techniques he has found most valuable in the context of Clawpack, an open-source software effort he has been leading for 20 years, and tsunami hazard assessment, one specific application of this software where accountability and reproducibility are particularly important.

Financing Global Health 2013: Transition in an Age of Austerity launches at the Center for Strategic & International Studies (CSIS), a public policy institution based in Washington, DC.